Conservative Judges Are Manipulating the History of Eugenics to Overturn Roe v. Wade
By Mark Joseph Stern,
Slate
| 04. 15. 2021
On Wednesday, the U.S. Court of Appeals for the 6th Circuit upheld an Ohio law that prohibits doctors from performing an abortion if they know the reason is because the fetus has been diagnosed with Down syndrome. The 9–7 decision seems to defy the Supreme Court’s decisions in Roe v. Wade and Planned Parenthood v. Casey, which found a constitutional right to terminate a pregnancy before viability. Yet the court’s conservative judges claimed that those precedents did not necessarily apply here, because Ohio was not simply regulating abortion; the state claimed to be combatting eugenics by protecting disabled fetuses from discrimination. The Supreme Court has never squarely confronted these “trait-selection” laws, which often forbid abortions because of race or sex as well; while these bans have cropped up around the country in recent years, courts have consistently ruled that they are foreclosed by precedent. The 6th Circuit’s conservative majority, by contrast, made a bet that today’s SCOTUS will weaken or overturn Roe and Casey to uphold Ohio’s statute—and, perhaps, overturn the constitutional right to abortion in the...
Related Articles
By Jacob M. Apel, The Baltimore Sun | 08.16.2024
By Neha Kondaveeti, The Austin Chronicle | 08.16.2024
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...